Glaukos (GKOS) Net Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,109.00 |
| Dec 31, 2025 | 5,924.00 |
| Sep 30, 2025 | 1,214.00 |
| Jun 30, 2025 | 11,058.00 |
| Mar 31, 2025 | 8,070.00 |
| Dec 31, 2024 | 5,301.00 |
| Sep 30, 2024 | 94.00 |
| Jun 30, 2024 | -4,206.00 |
| Mar 31, 2024 | -4,521.00 |
| Dec 31, 2023 | 11,971.00 |
| Sep 30, 2023 | -2,393.00 |
| Jun 30, 2023 | -2,826.00 |
| Mar 31, 2023 | -4,010.00 |
| Dec 31, 2022 | 9,566.00 |
| Sep 30, 2022 | -4,191.00 |
| Jun 30, 2022 | -5,465.00 |
| Mar 31, 2022 | 554.00 |
| Dec 31, 2021 | -5,620.00 |
| Sep 30, 2021 | 442.00 |
| Jun 30, 2021 | -3,055.00 |
| Mar 31, 2021 | -2,811.00 |
| Dec 31, 2020 | -18,466.00 |
| Sep 30, 2020 | -1,330.00 |
| Jun 30, 2020 | 5,671.00 |
| Mar 31, 2020 | -8,772.00 |
| Dec 31, 2019 | 8,583.00 |
| Sep 30, 2019 | -1,080.00 |
| Jun 30, 2019 | 1,170.00 |
| Mar 31, 2019 | 4,635.00 |